Updates in diabetes and kidney disease for the primary care physician

Hear the latest updates on diabetes and kidney disease testing and management for primary care physicians.

This interactive webinar session presented by specialist clinician researchers will present the latest updates in diabetes and kidney disease care relevant to primary care physicians. Topics covered include up-to-date descriptions of the local burden of diabetes and chronic kidney disease in Melbourne’s west, highlighting opportunities for improvements in care. The session will also review the latest guidelines on testing for detection and monitoring of disease and complications. 

Updates on treatment algorithms for diabetes and new treatment options for kidney disease will also be covered, highlighting the significant recent advances in this space. There will be additional focus on practical tips for commencing new medications and strategies for sick day management. 

As well as an update on the Royal Melbourne Hospital’s new Diabetes Remission Endo-Telehealth Rapid Access Clinics (DR Endo-TRACS).

Finally, there will be a direct question and answer session with the speakers. 

Speakers

Dr Hannah Wallace, Western Health

Dr Hannah Wallace is a nephrologist in Melbourne's west. She is undertaking her PhD with the University of Melbourne, exploring models of care to improve detection and management of kidney disease.

Dr Christopher Preston, Western Health

Dr Christopher Preston is an endocrinologist at Western Health, with clinical interests in diabetes and modern data analytical and patient-interface technologies. He is currently undertaking a PhD exploring innovative models of care aimed at improving clinical outcomes in diabetes. 

Associate Professor Spiros Fourlanos, MBBS, FRACP, PhD

Spiros Fourlanos is Director of the Royal Melbourne Hospital Department of Diabetes and Endocrinology, and honorary Associate Clinical Professor with the University of Melbourne. 

He obtained his medical and PhD degrees at the University of Melbourne. His doctoral thesis -- Latent Autoimmune Diabetes in Adults (LADA): New Clinical, Immunogenetic and Metabolic Perspectives -- was performed at the Walter & Eliza Hall Institute. 

He has authored over 100 peer-reviewed papers and is currently a stream lead in the University of Melbourne Australian Centre for Accelerating Diabetes Innovations (ACADI) collaborative. He is currently a board member and honorary treasurer of the Australian Diabetes Society.

Learning outcomes:

By the end of this activity, participants will be able to:

• Describe the local burden of diabetes and kidney disease
• Identify patients who will receive benefit from disease contemporary diabetic medications with cardio-renal benefit
• Explain the new chronic kidney disease guidelines (with a focus on primary care) and be able to prescribe new medications available for chronic kidney disease. 
• Explain the diabetic and kidney yearly cycle of care including when to refer to tertiary services